Diagnostic Kits & Kit-Based Analysis Infrastructure

Introduction and Positioning

Omega Bio is a complementary component of the Omega Lab ecosystem, providing a diagnostic kit–based analytical infrastructure for clinical research and diagnostic applications. Analyses performed using standardized, validated, and traceable kit platforms ensure data consistency and methodological alignment across study sites, central laboratories, and sponsor teams. Omega Bio solutions are structured to operate in full integration with HelixLab central laboratory operations. This integration aims to reduce methodological variability, minimize operator-dependent errors, and establish an audit-ready analytical environment, particularly in multicenter clinical studies.

Laboratory, analytical, and operational services provided within the Omega ecosystem are delivered through Omega’s internal units or authorized partner infrastructures that comply with applicable standards, depending on the nature of the study, regulatory requirements, and methodological scope.

Accreditations, certifications, and official authorizations apply at the level of the unit or partner organization where the service is actually performed and are assessed on a study-specific basis for each service category.

Overview of the Diagnostic Kit Portfolio

The diagnostic kits within the Omega Bio portfolio address the needs of clinical research and translational studies across the following core categories:

Immunological and serological kits

Antigen–antibody–based measurements, immune response assessments, and selected biomarker analyses.

ELISA and ligand-binding assay kits

Quantitative platforms for cytokines, hormones, protein biomarkers, and pharmacodynamics indicators.

Molecular diagnostic kits (DNA/RNA-based)

Standardized kits based on PCR and related molecular methods for genetic and virological analyses.

Rapid diagnostic and screening kits (protocol-dependent)

Solutions used for pre-screening or supportive analyses in accordance with study design.

Microbiology- and virology-focused diagnostic kits (general scope)

Platforms used for culture-independent, kit-based identification and confirmation approaches.

Scientific and Operational Advantages of a Kit-Based Analytical Approach

The diagnostic kit infrastructure provided by Omega Bio offers the following critical advantages in clinical research:

Method standardization: Use of identical kits and analytical principles across all sites and laboratories ensures data comparability.

Reduction of operator-dependent variability: Pre-defined and validated kit protocols minimize the impact of operator differences.

Audit and inspection compliance: Kit lot numbers, expiration dates, storage conditions, and usage records are documented in a fully traceable manner.

HelixLab integration: Home sampling, site-based samples, and central laboratory analyses are conducted using a harmonized kit infrastructure.

Scalability: Supports operational needs ranging from early-phase studies to late-phase, multicenter global trials.

Quality, Validation, and Regulatory Alignment

The Omega Bio diagnostic kit infrastructure is managed in alignment with clinical research quality expectations and regulatory requirements. Kit-based analyses are conducted in accordance with traceability, change management, and documentation integrity principles.

Role Within the Omega Lab Ecosystem

Omega Bio supports end-to-end standardization of analytical methodologies through integration with HelixLab central laboratory operations, Omega CRO activities, and site processes.

Clinical Research Scenarios

Early-phase clinical studies: Rapid screening and biomarker-supportive analyses. Multicenter studies: Methodological harmonization and data comparability. Translational projects: Bridging clinical and laboratory data. Pharmacodynamic and safety studies: ADA and therapeutic drug level monitoring

Why It Is Critical for Sponsors

Omega Bio’s kit-based analytical infrastructure reduces methodological risk, strengthens data integrity, and delivers an audit-ready operational model for sponsors. Standardized kit utilization minimizes site- and laboratory-related variability, supporting the generation of more reliable and regulatory-compliant clinical data.

Lateral Flow (Rapid Test) Kits

Lateral flow test kits are designed for site-based and mobile clinical research models where rapid results are required. They cover a broad product range including respiratory infections, gastrointestinal infections, women’s health, metabolic testing, animal health, and selected tumor marker screening.

  • Adenovirus Resp. Rapid Antigen Test
  • Flu AB Rapid Antigen Test
  • RSV & Flu AB Rapid Antigen Test
  • Strep A Rapid Antigen Test
  • RSV Rapid Antigen Test
  • SARS-CoV-2 & Flu AB Rapid Antigen Test
  • SARS-CoV-2 Rapid Antigen Test
  • Chlamydia trachomatis Rapid Antigen
  • Chlamydia trachomatis Rapid Antibody
  • Hepatitis C (HCV) Rapid Antibody
  • Hepatitis B (HBsAg) Rapid Antigen
  • HIV Rapid Antibody
  • Syphilis (Treponema pallidum) Rapid Antibody
  • Early Pregnancy Rapid Test
  • LH Rapid Test
  • Adenovirus-fecal Rapid Antigen
  • Entamoeba histolytic Rapid Antigen
  • Giardia Rapid Antigen
  • Helicobacter pylori Rapid Antibody / Antigen
  • Norovirus Rapid Antigen
  • Rotavirus & Adenovirus Rapid Antigen
  • Rotavirus Rapid Antigen
  • 25(OH)D Vitamin D Rapid Test
  • CRP (C-Reaktif Protein) Rapid Test
  • Ferritin Rapid Test
  • HbA1c Rapid Test
  • TSH Rapid Test
  • Canine Distemper / Parvovirus, Feline Parvovirus
  • FOB (Fecal Occult Blood) Rapid Test

These lateral flow kits are suitable for quick screening, on-site preliminary diagnosis, and supportive analyses, and can be used in conjunction with HelixLab’s field sampling processes.

RT-PCR Kits (Nucleic Acid Amplification)

RT-PCR kits provide high sensitivity and specificity for molecular diagnostics and confirmatory studies. They are used for infection diagnostics, genetic disease testing, and food and animal health analysis, and are implemented within the HelixLab molecular analysis infrastructure.
Integrated Workflow: Our home care services are integrated into the overall expanded access workflow, ensuring that home visits, patient monitoring, and data collection are synchronized with the central management system for optimal efficiency.

  • Group A Streptococcus qPCR Kit
  • RSV qPCR Kit
  • Salmonella Detection qPCR Kit
  • SARS-CoV-2 qPCR Kit
  • Respiratory Infection qPCR Panel (7)
  • (Bazı kitler geliştirme aşamasında)
  • SMA qPCR Kit
  • Wheat Adulteration qPCR Kit
  • Salmonella enteritidis/typhimurium qPCR Kit

RT-PCR kits play critical roles in clinical research, including the measurement of specific genetic targets, infection diagnostics, and molecular confirmation.

ELISA Kits and Ligand-Binding Assays

ELISA-based kits are used for quantitative protein-level measurements, including anti-drug antibody (Anti-Drug Antibody, ADA) assessments, therapeutic monoclonal antibody concentration measurements, and serological profiling.

These kits are used in the detection/measurement of anti-drug-antibodies in monoclonal antibody treatments.

  • Anti-Adalimumab, Anti-Bevacizumab, Anti-Cetuximab
  • Anti-Daratumumab, Anti-Dupilumab, Anti-Etanercept
  • Anti-Infliximab, Anti-Nivolumab, Anti-Ocrelizumab
  • Anti-Pembrolizumab, Anti-Ranibizumab, Anti-Risankizumab
  • Anti-Secukinumab, Anti-Trastuzumab, Anti-Ustekinumab
  • Anti-Vedolizumab, Anti-Drug Antibody (ADA) Detection Kits

For the measurement of concentrations of therapeutic monoclonal antibodies:

  • Adalimumab (Humira)
  • Bevacizumab (Avastin)
  • Cetuximab (Erbitux)
  • Daratumumab (Darzalex)
  • Dupilumab (Dupixent)
  • Etanercept (Enbrel)
  • Infliximab (Remicade)
  • Nivolumab (Opdivo)
  • Pembrolizumab (Keytruda)
  • Ocrelizumab (Ocrevus)
  • Ranibizumab (Lucentis)
  • Risankizumab (Skyrizi)
  • Trastuzumab (Herceptin)
  • Ustekinumab (Stelara)
  • Vedolizumab (Entyvio)
  • Secukinumab (Cosentyx)

Serologic profiling and immune response measurements:

  • Anti-SARS-CoV-2 Neutralizing Antibody ELISA Kit
  • COVID-19 S (Spike) Protein IgG ELISA Kit
  • COVID-19 N (Nucleokapsid) Protein IgG ELISA Kit